Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4792.60x is 94% below its 3-year average of -2464.56x, near the low end of its 3-year range (-4792.60x–-762.57x).
As of the fiscal period ended Saturday, September 30, 2023. 72.55% below its 12-month average of -2777.59x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2023 (2023-09-30): -4792.60x.
INTEREST COVERAGE RATIO
-4792.60x
INTEREST COVERAGE RATIO AVG TTM
-2777.59x
INTEREST COVERAGE RATIO AVG 3Y
-2464.56x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-72.55%
CURRENT VS 3Y AVG
-94.46%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-74319.25%
vs the sector median at left
Tyra Biosciences, Inc.
Market Cap
$1.21B
Interest Coverage Ratio
-4792.60x
TTM Avg
-2777.59x
3Y Avg
-2464.56x
5Y Avg
N/A
Market Cap
$1.20B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.22B
Interest Coverage Ratio
15.57x
TTM Avg
15.57x
3Y Avg
15.57x
5Y Avg
10.02x
Market Cap
$1.23B
Interest Coverage Ratio
N/A
TTM Avg
1.72x
3Y Avg
1.72x
5Y Avg
1.72x
Market Cap
$1.18B
Interest Coverage Ratio
2.81x
TTM Avg
2.36x
3Y Avg
1.69x
5Y Avg
1.69x
Market Cap
$1.24B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
Interest Coverage Ratio
-4.99x
TTM Avg
16.08x
3Y Avg
16.08x
5Y Avg
16.08x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | $1.21B | -4792.60x | -2777.59x | -2464.56x | N/A |
| Kardigan, Inc. (KARD)vs › | $1.21B | N/A | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | N/A | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 15.57x | 15.57x | 15.57x | 10.02x |
| Cronos Group Inc. (CRON)vs › | $1.23B | N/A | 1.72x | 1.72x | 1.72x |
| MannKind Corporation (MNKD)vs › | $1.18B | 2.81x | 2.36x | 1.69x | 1.69x |
| Omada Health (OMDA)vs › | $1.23B | -4.72x | N/A | N/A | N/A |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.14B | -4.99x | 16.08x | 16.08x | 16.08x |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 5.51x | 6.14x | 19.44x | 31.00x |
Interest Coverage
-4792.6x
Debt/Equity
0.02
Current Ratio
14.91
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-09-30 | -4792.60x |
| 2023-06-30 | -762.57x |
| 2020-12-31 | -1838.50x |
